Prof. Lanjuan Li's Group Proposed Novel Li's Artificial Liver System for Treating Liver Failure in t

Researchers Reveal the Secrete of Nonrandom DNA Seg-regation in Human Cells

2016-01-25 |

Acute liver failure (ALF) is a significant disorder with a high mortality rate of 55%–75% and causes large resource costs. Liver transplantation is the standard therapy for patients with liver failure; however, less than 30% of patients on the waiting lists receive a transplant because of the shortage of organ donors. Thus, artiﬁcial liver systems (ALS), with the primary goal to provide blood detoxiﬁcation, are widely used in clinics to compensate the liver function until the patient’s native liver regenerates, or a liver donor is available for transplantation.